Photo of Megan Murray

Megan Murray, M.D., Sc.D.

Ronda Stryker and William Johnston Professor of Global Health, Harvard Medical School
Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health
Associate Professor of Medicine, Brigham and Women's Hospital
Director of Research, Global Health & Social Medicine, Harvard Medical School

Megan Murray, MD, MPH, ScD is an epidemiologist and an infectious disease physician with over 25 years of experience in the management of TB programs and TB epidemiology, as well as the transmission dynamics of emerging infectious diseases. She is a Professor of Global Health and Social Medicine and an Associate Professor of Medicine at Harvard Medical School, where she leads the Global Health Research Core, a multidisciplinary group of researchers who work with the Global Health Delivery Partnership faculty and staff to develop its mission to link research to the teaching and service activities of the Partnership. She is also a Professor of Epidemiology at Harvard School of Public Health and the Director of Research at the Brigham and Women’s Hospital Division of Global Health Equity and its sister organization, Partners In Health.  Dr. Murray has conducted field studies in Peru, Rwanda, South Africa, Ukraine, Russia and the US, and has previously worked in Kenya, Niger and Pakistan. Her current interests include identifying ways to reduce the suffering caused by the health impacts of climate change, especially in low and middle income countries.

Address: 
Department of Global Health and Social Medicine
641 Huntington Avenue
Boston, MA 02115

Alternative email address: mmurray@hsph.harvard.edu

Dr. Murray’s research focuses on host and pathogen specific determinants of TB infection, disease and treatment outcomes. Much of her research is done in collaboration with the non-governmental organization Partners in Health and its Peru-based sister organization Socios en Salud. The joint team uses bacterial and human genetic and genomic tools to identify variants of interest and to understand the mechanisms of their interactions.

In addition to her work in Peru, Dr. Murray has conducted field studies in South Africa, Russia, the US, India, Indonesia, Sierra Leone, Pakistan, Niger and Rwanda. She serves as an editor for PLoS Medicine and for the European Journal of Epidemiology. She is currently a member of the Mass Consortium for Pathogen Readiness leadership team as well as Harvard University’s Covid Monitoring Committee. She has also served on numerous other committees, including the WHO’s TB-STAG, the Stop TB MDR Working Group, Harvard University Human Subjects Committee, the University’s Pandemic Flu Advisory Committee, the Institute of Medicine committee on Gulf War and Infectious Diseases, and multiple NIH study sections.

Recurrence after treatment for pulmonary multidrug-resistant tuberculosis.
Authors: Authors: Becerra MC, Appleton SC, Franke MF, Chalco K, Bayona J, Murray MB, Mitnick CD.
Clin Infect Dis
View full abstract on Pubmed
Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality?
Authors: Authors: Boulle A, Clayden P, Cohen K, Cohen T, Conradie F, Dong K, Geffen N, Grimwood A, Hurtado R, Kenyon C, Lawn S, Maartens G, Meintjes G, Mendelson M, Murray M, Rangaka M, Sanne I, Spencer D, Taljaard J, Variava E, Venter WD, Wilson D.
S Afr Med J
View full abstract on Pubmed
Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis.
Authors: Authors: Jacobson KR, Tierney DB, Jeon CY, Mitnick CD, Murray MB.
Clin Infect Dis
View full abstract on Pubmed
The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study.
Authors: Authors: Cohen T, Murray M, Wallengren K, Alvarez GG, Samuel EY, Wilson D.
PLoS Med
View full abstract on Pubmed
Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis.
Authors: Authors: Harries AD, Murray MB, Jeon CY, Ottmani SE, Lonnroth K, Barreto ML, Billo N, Brostrom R, Bygbjerg IC, Fisher-Hoch S, Mori T, Ramaiya K, Roglic G, Strandgaard H, Unwin N, Viswanathan V, Whiting D, Kapur A.
Trop Med Int Health
View full abstract on Pubmed
Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages.
Authors: Authors: Johnson EE, Srikanth CV, Sandgren A, Harrington L, Trebicka E, Wang L, Borregaard N, Murray M, Cherayil BJ.
FEMS Immunol Med Microbiol
View full abstract on Pubmed
Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.
Authors: Authors: Calver AD, Falmer AA, Murray M, Strauss OJ, Streicher EM, Hanekom M, Liversage T, Masibi M, van Helden PD, Warren RM, Victor TC.
Emerg Infect Dis
View full abstract on Pubmed
The impact of realistic age structure in simple models of tuberculosis transmission.
Authors: Authors: Brooks-Pollock E, Cohen T, Murray M.
PLoS One
View full abstract on Pubmed
Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study.
Authors: Authors: Lin HH, Ezzati M, Chang HY, Murray M.
Am J Respir Crit Care Med
View full abstract on Pubmed
Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production.
Authors: Authors: Colijn C, Brandes A, Zucker J, Lun DS, Weiner B, Farhat MR, Cheng TY, Moody DB, Murray M, Galagan JE.
PLoS Comput Biol
View full abstract on Pubmed